Patient education : Patients need support as they work to understand their medical, dietary, and lifestyle choices
However, tirzepatide side effects may be more intense due to dual action
Prescribed for individuals with obesity
December 2025: Growing integration of GLP-1 therapies in Japan's diabetes clinics and hospitals, driven by increasing obesity-related comorbidities and demand for convenient administration routes
4.7 Avg Rating 502 total reviews 100% 4+ Stars of top 10 2 Accept Insurance confirmed of 10 6 Offer Telehealth confirmed of 10 Our rankings are based on a weighted scoring system that considers multiple factors
The researchers focused only on patients with type 2 diabetes because their prescriptions were tracked through 2018, when GLP-1 drugs were still approved only for diabetes, explained Lindsey Wang, the lead author and a sophomore at Case Western Reserve University who has been studying under the senior author, the late Nathan Berger, for the past five years